Embecta Corp. (NASDAQ:EMBC) Shares Sold by Ceera Investments LLC

by · The Cerbat Gem

Ceera Investments LLC trimmed its stake in shares of Embecta Corp. (NASDAQ:EMBC – Free Report) by 3.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 172,654 shares of the company’s stock after selling 5,699 shares during the quarter. Ceera Investments LLC owned 0.30% of Embecta worth $2,434,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. AQR Capital Management LLC lifted its holdings in Embecta by 136.2% during the 2nd quarter. AQR Capital Management LLC now owns 614,645 shares of the company’s stock worth $7,683,000 after buying an additional 354,454 shares during the last quarter. Jacobs Levy Equity Management Inc. lifted its holdings in shares of Embecta by 95.3% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 643,230 shares of the company’s stock valued at $8,536,000 after purchasing an additional 313,951 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Embecta by 2.7% in the 1st quarter. Vanguard Group Inc. now owns 7,213,992 shares of the company’s stock valued at $95,730,000 after purchasing an additional 187,916 shares during the last quarter. Mercer Global Advisors Inc. ADV purchased a new stake in shares of Embecta in the 2nd quarter valued at about $1,663,000. Finally, AXA S.A. purchased a new stake in shares of Embecta in the 2nd quarter valued at about $1,595,000. 93.83% of the stock is owned by institutional investors and hedge funds.

Embecta Stock Performance

Embecta stock opened at $14.62 on Friday. Embecta Corp. has a fifty-two week low of $9.93 and a fifty-two week high of $19.79. The company has a market capitalization of $843.57 million, a P/E ratio of 12.18 and a beta of 0.97. The stock has a 50-day simple moving average of $14.55 and a 200-day simple moving average of $13.88.

Embecta Company Profile

(Free Report)

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.

Featured Articles

Want to see what other hedge funds are holding EMBC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Embecta Corp. (NASDAQ:EMBC – Free Report).